BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 6614963)

  • 1. Small volume plasmapheresis in the management of porphyria cutanea tarda.
    Miyauchi S; Shiraishi S; Miki Y
    Arch Dermatol; 1983 Sep; 119(9):752-5. PubMed ID: 6614963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of a case of porphyria cutanea tarda by plasmapheresis].
    Dupré A; Bonafé JL; Callot JP; Campardou AM; Nabulsi-Kassas M; Snapir G; Augustin C
    Ann Dermatol Venereol; 1980 Jul; 107(7):693-5. PubMed ID: 7436265
    [No Abstract]   [Full Text] [Related]  

  • 3. Porphyria cutanea tarda treated by repeated venesection: clinical and biochemical response.
    Baker H; Turnbull A
    Proc R Soc Med; 1969 Jun; 62(6):590-2. PubMed ID: 5802737
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trial of the treatment of porphyria cutanea tarda by plasmapheresis].
    Gasior-Chrzan B; Wasik F; Partyka T; Gamin E
    Przegl Dermatol; 1985; 72(3):294-7. PubMed ID: 3909235
    [No Abstract]   [Full Text] [Related]  

  • 5. Porphyria cutanea tarda. Diagnosis, management, and differentiation from other hepatic porphyrias.
    Grossman ME; Poh-Fitzpatrick MB
    Dermatol Clin; 1986 Apr; 4(2):297-309. PubMed ID: 3955900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3 cases of porphyria cutanea tarda--change of urinary porphyrin excretion patterns after phlebotomy].
    Murayama F; Ohgami T; Honda T; Rikimaru M; Hirowatari T; Nonaka S; Yoshida H
    Nihon Hifuka Gakkai Zasshi; 1983 Aug; 93(9):909-15. PubMed ID: 6663799
    [No Abstract]   [Full Text] [Related]  

  • 7. [Porphyrin metabolic disorders in porphyria cutanea tarda].
    Krivosheev BN
    Vestn Dermatol Venerol; 1989; (8):67-71. PubMed ID: 2816038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Small volume plasma exchange therapy in patients with porphyria cutanea tarda on maintenance hemodialysis].
    Toriyama T; Kawahara H
    Nihon Rinsho; 1992 Jan; 50 Suppl():423-8. PubMed ID: 1578718
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of treatment of porphyria cutanea tarda with bloodletting and chloroquine].
    Seubert S; Seubert A; Stella AM; Guzman H; Batlle A
    Z Hautkr; 1990 Mar; 65(3):223-5. PubMed ID: 2339575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experiences with iron elimination therapy in porphyria cutanea tarda].
    Haneke E; Schwartze G
    Z Gesamte Inn Med; 1971 Nov; 26(22):710-6. PubMed ID: 5141034
    [No Abstract]   [Full Text] [Related]  

  • 11. [Porphyria cutanea tarda in a chronic hemodialysis patient].
    Kawabe M; Matsumoto Y; Yasue T; Toriyama T; Kondo M
    Nihon Hifuka Gakkai Zasshi; 1990 Apr; 100(5):589-96. PubMed ID: 2395221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fecal porphyrin analyses in patients with porphyria cutanea tarda].
    Nonaka S; Ohgami T; Nagato N; Watanabe M; Yoshida H; Murayama F; Irifune H; Yamashita K
    Nihon Hifuka Gakkai Zasshi; 1987 Feb; 97(2):151-6. PubMed ID: 3599490
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of the treatment of porphyria cutanea tarda on the changes of the urinary porphyrin pattern (determined by high performance liquid chromatography) and histopathological aspects of the liver].
    Cainelli T; Marchesi L; De Padova C; Reseghetti A
    G Ital Dermatol Venereol; 1984; 119(3):171-4. PubMed ID: 6746012
    [No Abstract]   [Full Text] [Related]  

  • 14. Patterns of porphyrin excretion in porphyria cutanea tarda under venesection treatment.
    Enríquez de Salamanca R; Rico R; Peña ML; Romero F; Olmos A; Jimenez J
    Int J Biochem; 1980; 12(5-6):861-8. PubMed ID: 7450142
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythropoietin as treatment of haemodialysis-related porphyria cutanea tarda.
    Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Bianco L; Salvadeo A; Barosi G
    Nephrol Dial Transplant; 1992; 7(5):438-42. PubMed ID: 1321381
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intestinal absorption of iron observed in 2 cases of porphyria cutanea tarda].
    Cupella F; Pozzi U; Carena M; Schiavi A; Colombi R
    G Ital Med Lav; 1984; 6(5-6):259-60. PubMed ID: 6545217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of clinical and chemical studies in porphyria cutanea tarda].
    Formanek I; Niebauer G
    Wien Z Inn Med; 1966 Nov; 47(11):438-44. PubMed ID: 6005177
    [No Abstract]   [Full Text] [Related]  

  • 18. Recovery from porphyria cutanea tarda with no specific therapy other than avoidance of hepatic toxins.
    Topi GC; Amantea A; Griso D
    Br J Dermatol; 1984 Jul; 111(1):75-82. PubMed ID: 6743539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Artefacts in porphyria cutanea tarda].
    Egger B; Goerz G
    Z Hautkr; 1990 Jun; 65(6):592, 595-6. PubMed ID: 2389593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diet and alcohol effects on the manifestation of hepatic porphyrias.
    Cripps DJ
    Fed Proc; 1987 Apr; 46(5):1894-900. PubMed ID: 3556614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.